NASDAQ NMS - GLOBAL MARKET · FTH
+8.47% · +$2.71 · Vol 448.5K
Market closed · last close 4:00 PM ET · price as of 16:00:52 ET
Faeth Therapeutics, Inc

Faeth Therapeutics, Inc

Biotechnology
$34.71
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
FTH
Faeth Therapeutics, Inc
Mon Aug 24 · market closed · Markets closed · resumes Tue 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

77/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Mon Aug 24 · market closed · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is FTH moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading FTH catalysts
About Faeth Therapeutics, Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2021
Employees
29
Country
US

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$32.80
Day high
$35.05
Day low
$30.30
Previous close
$32.00
52W high
$36.16
-4.01% from high
52W low
$14.53
93% of range
Market cap
$826.9M
EPS
$-11.3600
Beta
-0.03
Shares out
25.8M
Volume
448.5K
1.41× rel vol
Avg volume
318.4K
VWAP
$34.06
Price history computed in-house
1W
+5.18%
1M
+22.69%
SMA 50 Not reported · Not reported
SMA 200 Not reported · Not reported
52W position 93%

FTH overview

Veridion Score
77
Registered · 2026-08-24
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around FTH.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading FTH Form 4 filings
Public disclosures

Congress activity in FTH

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for FTH in the cached public ledger.

Federal contracts

FTH contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for FTH in this window.
Lobbying spend

FTH lobbying filings, year to date.

Registered lobbying filings matched to Faeth Therapeutics, Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for FTH in this window.
Loading news for FTH
Analyst ratings
Sovereign unlock shows live analyst consensus for FTH.
Options
Sovereign unlock shows live options positioning for FTH.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.